Sulfasalazine an Inhibitor of System x C − (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction
Anticancer Research · 2026
DOI: 10.21873/anticanres.18122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Jinsoo Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Sulfasalazine, Colonic Neoplasms, Cysteine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc., San Diego, CA, U.S.A.
- Department of Surgery, University of California San Diego, La Jolla, Ca, U.S.A.
- Department of Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
- AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.
Zitieren
APA
Kim, J., Han, Q., Li, S., Kang, B. M., Miyashi, Y., Ishiguro, T., Bouvet, M., & Hoffman, R. M. (2026). Sulfasalazine an Inhibitor of System x C − (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction. Anticancer Research. https://doi.org/10.21873/anticanres.18122
Vancouver
Kim J, Han Q, Li S, Kang BM, Miyashi Y, Ishiguro T, et al. Sulfasalazine an Inhibitor of System x C − (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction. Anticancer Research. 2026. doi:10.21873/anticanres.18122
BibTeX
@article{Kim2026,
author = {Kim, Jinsoo and Han, Qinghong and Li, Shukuan and Kang, Byung Mo and Miyashi, Yuta and Ishiguro, Tomoyuki and Bouvet, Michael and Hoffman, Robert M},
title = {Sulfasalazine an Inhibitor of System x C − (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18122}
}
EUVIMED